122 related articles for article (PubMed ID: 18234195)
1. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury.
Yildirim F; Gertz K; Kronenberg G; Harms C; Fink KB; Meisel A; Endres M
Exp Neurol; 2008 Apr; 210(2):531-42. PubMed ID: 18234195
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation.
Meisel A; Harms C; Yildirim F; Bösel J; Kronenberg G; Harms U; Fink KB; Endres M
J Neurochem; 2006 Aug; 98(4):1019-31. PubMed ID: 16895577
[TBL] [Abstract][Full Text] [Related]
3. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats.
Ma XH; Gao Q; Jia Z; Zhang ZW
Int J Neurosci; 2015 Feb; 125(2):140-6. PubMed ID: 24730998
[TBL] [Abstract][Full Text] [Related]
5. Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury.
Yildirim F; Ji S; Kronenberg G; Barco A; Olivares R; Benito E; Dirnagl U; Gertz K; Endres M; Harms C; Meisel A
PLoS One; 2014; 9(4):e95465. PubMed ID: 24748101
[TBL] [Abstract][Full Text] [Related]
6. Protection against reperfusion lung injury via aborgating multiple signaling cascades by trichostatin A.
Hsu HH; Wu SY; Tang SE; Wu GC; Li MH; Huang KL; Chu SJ
Int Immunopharmacol; 2015 Apr; 25(2):267-75. PubMed ID: 25698558
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
Mulholland NM; Soeth E; Smith CL
Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
Sng JC; Taniura H; Yoneda Y
Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of gelsolin expression in human breast cancer cells.
Mielnicki LM; Ying AM; Head KL; Asch HL; Asch BB
Exp Cell Res; 1999 May; 249(1):161-76. PubMed ID: 10328963
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.
Faraco G; Pancani T; Formentini L; Mascagni P; Fossati G; Leoni F; Moroni F; Chiarugi A
Mol Pharmacol; 2006 Dec; 70(6):1876-84. PubMed ID: 16946032
[TBL] [Abstract][Full Text] [Related]
12. Interplay between histone acetylation/deacetylation and poly(ADP-ribosyl)ation in the development of ischemic tolerance in vitro.
Gerace E; Landucci E; Scartabelli T; Moroni F; Chiarugi A; Pellegrini-Giampietro DE
Neuropharmacology; 2015 May; 92():125-34. PubMed ID: 25623965
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression.
Fang YC; Chan L; Liou JP; Tu YK; Lai MJ; Chen CI; Vidyanti AN; Lee HY; Hu CJ
J Cell Mol Med; 2020 Jun; 24(12):6966-6977. PubMed ID: 32374084
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibitor prevents LPS mediated inhibition of CYP19A1 expression and 17β-estradiol production in granulosa cells.
Mehta A; Ravinder ; Onteru SK; Singh D
Mol Cell Endocrinol; 2015 Oct; 414():73-81. PubMed ID: 26213324
[TBL] [Abstract][Full Text] [Related]
15. Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemia.
Cheng J; Uchida M; Zhang W; Grafe MR; Herson PS; Hurn PD
J Cereb Blood Flow Metab; 2011 Jan; 31(1):339-50. PubMed ID: 20588319
[TBL] [Abstract][Full Text] [Related]
16. The p53-independent nuclear translocation of cyclin G1 in degenerating neurons by ischemic and traumatic insults.
Maeda M; Ampo K; Kiryu-Seo S; Konishi H; Ohba N; Kadono C; Kiyama H
Exp Neurol; 2005 Jun; 193(2):350-60. PubMed ID: 15869937
[TBL] [Abstract][Full Text] [Related]
17. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
[TBL] [Abstract][Full Text] [Related]
18. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer.
Rybouchkin A; Kato Y; Tsunoda Y
Biol Reprod; 2006 Jun; 74(6):1083-9. PubMed ID: 16481594
[TBL] [Abstract][Full Text] [Related]
19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
Seo J; Jo SA; Hwang S; Byun CJ; Lee HJ; Cho DH; Kim D; Koh YH; Jo I
FEBS J; 2013 Dec; 280(24):6691-701. PubMed ID: 24200051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
